Vaccination With LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients--Report of a Phase I/IIa Clinical Trial

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-15-1212

Related search